Sana Biotechnology Stock Target Price and Analyst Consensus
SANA Stock | USD 10.04 0.04 0.40% |
The current analyst and expert consensus on Sana Biotechnology is Buy, with 2 strong buy opinions. The current projected Sana Biotechnology target price consensus is 10.00 with 7 analyst opinions. The most common way Sana Biotechnology analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Sana Biotechnology executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Sana Biotechnology. We strongly encourage you to use your own analysis of Sana Biotechnology to validate this buy or sell advice. Sana Biotechnology buy-or-sell recommendation module provides average expert sentiment on the projected Sana Biotechnology target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Sana Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.
Lowest Forecast 9.1 | Highest Forecast 11.1 | Target Price 10 |
Sana |
It's important to approach Sana Biotechnology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Sana Biotechnology price targets
Sana Biotechnology's stock target price is an estimate of its future price, usually made by analysts. Using Sana Biotechnology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Sana Biotechnology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Sana Biotechnology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Sana Biotechnology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Sana Biotechnology is a key component of Sana Biotechnology valuation and have some predictive power on the future returns of a Sana Biotechnology.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sana Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.ESG Investing Invested few shares | ||
Momentum Invested few shares | ||
Impulse Invested over 100 shares | ||
Power Assets Invested over 200 shares | ||
Hedge Favorites Invested over 70 shares | ||
Banking Invested over 30 shares | ||
Investor Favorites Invested over 40 shares | ||
Check out Macroaxis Advice on Sana Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
The data published in Sana Biotechnology's official financial statements usually reflect Sana Biotechnology's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Sana Biotechnology. For example, before you start analyzing numbers published by Sana accountants, it's critical to develop an understanding of what Sana Biotechnology's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Sana Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sana Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Sana Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sana Biotechnology. Please utilize our Beneish M Score to check the likelihood of Sana Biotechnology's management manipulating its earnings.